NCT06364358 Interactive Computer-adaptive Chronic Kidney Disease Education Program
| NCT ID | NCT06364358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Chronic Kidney Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-05-31 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-05-31 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot clinical trial is to evaluate a culturally tailored computerized education program in hospitalized African-American patients with advanced chronic kidney disease (CKD). The main question it aims to answer are: does computerized adaptive education (CAE) increase patients' knowledge about CKD self-care and renal replacement therapy (RRT) options compared to usual care (UC) and will CAE will be increase patients' intent to participate in CKD self-care and RRT preparation compared to UC
Eligibility Criteria
Inclusion Criteria: * African-American inpatients * Ages 18-70 * estimated glomerular filtration rate (eGFR)\<45 * Enrolled in the Hospitalist Project Exclusion Criteria: * Does not self-identify as African American * Not able to consent * Unable to speak English * eGFR \<45 due to acute kidney injury * In Intensive Care Unit * has had a transplant * currently on dialysis
Contact & Investigator
Milda Saunders, MD
PRINCIPAL INVESTIGATOR
Associate Professor of Medicine
Frequently Asked Questions
Who can join the NCT06364358 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06364358 currently recruiting?
Yes, NCT06364358 is actively recruiting participants. Contact the research team at msaunder@bsd.uchicago.edu for enrollment information.
Where is the NCT06364358 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06364358 clinical trial?
NCT06364358 is sponsored by University of Chicago. The principal investigator is Milda Saunders, MD at Associate Professor of Medicine. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.